Shun Kishimoto1, Jeeva Munasinghe2, Marcelino Bernardo1, Hellmut Merkle3, Keita Saito1, James B Mitchell1, Jan Henrik Ardenkjaer-Larsen4, Peter L Choyke1, and Murali Cherukuri1
1NCI, Bethesda, MD, United States, 2NINDS, Bethesda, MD, United States, 3LFMI, Bethesda, MD, United States, 4GE Health Care, brondby, Denmark
Synopsis
Photoimmunotherapy (PIT) is a novel
therapy for cancer treatment. PIT
combines a targeted antibody with the photon absorber, IR700, which, after
exposure to near infrared (NIR) light induces highly selective tumor necrosis
with almost no side effects to normal adjacent tissue. PIT is now in Phase I
clinical trials in head and neck cancers. Although NIR PIT can be highly effective, the
size of the lesion does not immediately change and it may take several weeks
for the tumor to completely respond anatomically. Thus, detecting early therapeutic response in
the absence of anatomic change is of interest. Here, we demonstrate the effects
of NIR PIT on 13C magnetic resonance spectroscopy (MRS) in an animal model
(EGFR positive A431 tumor) using 13C labeled hyperpolarized (HP) pyruvate and
fumarate. Interestingly, the lactate-to-pyruvate ratio was almost unchanged,
while the malate-to-fumarate ratio showed a significant difference in PIT treated
tumors. This is explained by the difference of the bio distribution of these
tracers. Hyperpolarized 13C labeled fumarate
MRS is a promising method for detecting early PIT mediated cell necrosis.Purpose
Photoimmunotherapy (PIT) is a
novel therapy for cancer treatment. (1) PIT is induced by an antibody-photon
absorber conjugate that, when exposed to near infrared light (NIR), induces tumor
cell necrosis. Previously, we have
demonstrated that NIR PIT is an oxygen dependent process (2). Early experience with NIR PIT demonstrates
that while the tumor may become necrotic, its size does not immediately change
and so it can be difficult to assess early treatment effectiveness. We explored the use of 13C-hyperpolarized MRS
before and after NIR-PIT to better understand the early metabolic changes in
this treatment.
[1,4-13C2] Fumarate is a 13C labeled
tracer for MRS, which can be used to identify tissue necrosis. Fumarate only
distributes in the extracellular space where there is a low level of fumarate
hydratase (FH). However, in necrosis, FH leaks out of the damaged cell and converts fumarate to
malate which is detected on MRS. In
contrast 13C pyruvate is readily
transported across the membrane and converted to
lactate by lactose dehydrogenase (LDH), a process that generally occurs
intracellularly but can also occur extracellularly.
Methods
A431 tumor bearing mice were assigned
to 4 groups (n=4 each) including non-treated and treated 13C Pyruvate and 13C
Fumarate in separate cohorts. ; Dynamic 13C spectra were obtained from each
group after hyperpolarization and injection in animals (see details below).
Samples of [1-13C] pyruvic acid
(30 μL) and [1,4-13C] fumaric acid (30 μL 2.5M in DMSO) containing 15 mM of
OX063 and 2.5 mM of the gadolinium chelate ProHance were polarized at 3.35 T
and 1.4 K in the Hypersense DNP polarizer. Each hyperpolarized sample was rapidly
dissolved in 4.5 mL of dissolution buffer and injected (12 μL/g body weight)
intravenously. Hyperpolarized 13C MRI studies were performed on a 3T scanner
using a 17-mm home-built 13C solenoid coil placed inside a saddle coil. The 13C
spectra were acquired every second with a spectral width of 3330 Hz, repetition
time of 1000ms and flip angle of 10°. Photoacoustic imaging was performed by
using the Vevo LAZR (VisualSonics) 21-MHz linear-array transducer system.
Photoacoustic mode was then initialized and switched to the oxy/hemo mode to
measure sO2 with the following parameters: transducer, LZ-250; depth, 20.00 mm;
width, 23.04 mm; wavelength, 750 and 850 nm, total hemoglobin concentration
threshold (Hbt), 20 arbitrary units (au); acquisition, sO2/Hbt.
Results and Discussion
Real time sO2 mapping showed rapid decreases
in local oxygenation suggesting oxygen consumption and conversion to singlet oxygen
that mediated membrane damage during PIT. Histologic analysis confirmed immediate
cell damage after PIT. Tumor growth curves showed the strong anti-tumor effect
of PIT. Dynamic spectra of 13C labeled pyruvate and fumarate showed that the
lactate-to-pyruvate ratio was unchanged after PIT, while the malate-to-fumarate
ratio increased 5 fold in the PIT treated group.
Since pyruvate is a tracer that can be easily
taken up into the cell via monocarboxylate transporter, its conversion to
lactate is independent of membrane damage. Fumarate, on the other hand is
restricted to the extracellular space and is converted to malate at a higher
rate only when FH leaks from necrotic cells, as occurs in early PIT. Thus, 13C fumarate hyperpolarized MRS
demonstrates the early effects of NIR PIT-induced necrosis.
Conclusion
Using
MRS after injection of hyperpolarized substrates, we demonstrate that the
malate-to -fumarate ratio increased 5 fold in NIR PIT treated tumors whereas
the lactate to pyruvate ratio was unchanged.
The conversion of fumarate to
malate supports a necrotic cell death mechanism for PIT. 13C labeled fumarate is thus, a promising
tracer for the early detection of PIT mediated cell death.
Acknowledgements
This study was supported by
intramural research program of NCI/NIH.References
(1)
Mitsunaga, M., Ogawa, M., Kosaka, N., Rosenblum,
L. T., Choyke, P. L., & Kobayashi, H. (2011). Cancer cell-selective in vivo
near infrared photoimmunotherapy targeting specific membrane molecules. Nature
Medicine, 17(12), 1685–91.
(2)
Kishimoto, S., Bernardo, M., Saito, K., Koyasu,
S., Mitchell, J. B., Choyke, P. L., & Krishna, M. C. (2015). Evaluation of
oxygen dependence on in vitro and in vivo cytotoxicity of photoimmunotherapy
using IR-700-antibody conjugates. Free Radical Biology & Medicine, 85,
24–32.
(3)
Mignion, L., Dutta, P., Martinez, G. V,
Foroutan, P., Gillies, R. J., & Jordan, B. F. (2014). Monitoring
chemotherapeutic response by hyperpolarized 13C-fumarate MRS and diffusion MRI.
Cancer Research, 74(3), 686–94.